Overview An Ontario university-led collaboration has turned heads in the medical community by using artificial intelligence to advance an antibiotic treatment for Crohn’s disease and inflammatory bowel disease (IBD). McMaster University researchers, led by Jon Stokes and working with partners at the Massachusetts Institute of Technology (MIT), say their AI-driven approach could shorten development time…